In the last 12 months, insiders at Coya Therapeutics, Inc. ($COYA) filed 43 transactions with the SEC: 5 open-market purchases totaling $110,013 and 0 sales totaling $0. Net insider sentiment: net buying.
Coya Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Swaminathan Arun (Chief Executive Officer) — 4 transactions totaling $73,486
- Grossman Fred (Chief Medical Officer) — 6 transactions totaling $19,973
- GOLDSTEIN DOV A MD (Director) — 3 transactions totaling $19,137
- SNYDER DAVID S (Chief Financial Officer) — 5 transactions totaling $12,934
- Lee Ann (Director) — 2 transactions totaling $3,620
View all SEC Filings for Coya Therapeutics, Inc. (COYA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 22, 2026 | SNYDER DAVID S | Chief Financial Officer | A | Stock Option (right to buy) | 140041 | $0.00 | 140,041.0000 | 20,924,456 | 9999.99% | 0.67% |
| Jan. 22, 2026 | Grossman Fred | Chief Medical Officer | A | Stock Option (right to buy) | 140041 | $0.00 | 140,041.0000 | 20,924,456 | 9999.99% | 0.67% |
| Jan. 22, 2026 | Swaminathan Arun | Chief Executive Officer | A | Stock Option (right to buy) | 293983 | $0.00 | 293,983.0000 | 20,924,456 | 9999.99% | 1.41% |
| Jan. 22, 2026 | Berman Howard | Executive Chairman | A | Stock Option (right to buy) | 15257 | $0.00 | 15,257.0000 | 20,924,456 | 9999.99% | 0.07% |
| Jan. 2, 2026 | Villalobos Anabella | Not found | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 20,924,456 | 9999.99% | 0.05% |
| Jan. 2, 2026 | Lee Ann | Not found | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 20,924,456 | 9999.99% | 0.05% |
| Jan. 2, 2026 | ROSS WILBUR L JR | Not found | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 20,924,456 | 9999.99% | 0.05% |
| Jan. 2, 2026 | Weinand Dieter | Not found | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 20,924,456 | 9999.99% | 0.05% |
| Jan. 2, 2026 | GOLDSTEIN DOV A MD | Not found | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 20,924,456 | 9999.99% | 0.05% |
| Aug. 18, 2025 | GOLDSTEIN DOV A MD | Director | M | Stock Option (right to buy) | 17557 | $0.00 | 0.0000 | 16,724,998 | 100.00% | 0.10% |
| Aug. 18, 2025 | GOLDSTEIN DOV A MD | Director | M | Common Stock, par value $0.0001 per share | 17557 | $1.09 | 27,557.0000 | 16,724,998 | 175.57% | 0.10% |
| Feb. 25, 2025 | Weinand Dieter | Not found | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 25, 2025 | Lee Ann | Not found | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 25, 2025 | Villalobos Anabella | Not found | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 25, 2025 | GOLDSTEIN DOV A MD | Not found | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 25, 2025 | ROSS WILBUR L JR | Not found | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2025 | SNYDER DAVID S | Chief Financial Officer | A | Stock Option (right to buy) | 140562 | $0.00 | 140,562.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2025 | Swaminathan Arun | Chief Executive Officer | A | Stock Option (right to buy) | 240964 | $0.00 | 240,964.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2025 | Grossman Fred | Chief Medical Officer | A | Stock Option (right to buy) | 140562 | $0.00 | 140,562.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2025 | Berman Howard | Not found | A | Stock Option (right to buy) | 150602 | $0.00 | 150,602.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2025 | Weinand Dieter | Not found | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2025 | Villalobos Anabella | Not found | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2025 | GOLDSTEIN DOV A MD | Not found | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2025 | ROSS WILBUR L JR | Not found | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2025 | Lee Ann | Not found | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | SNYDER DAVID S | Chief Financial Officer | P | Common Stock, par value $0.0001 per share | 1800 | $7.19 | 8,800.0000 | 0 | 25.71% | 0.00% |
| Nov. 13, 2024 | Swaminathan Arun | Chief Executive Officer | P | Common Stock, par value $0.0001 per share | 5000 | $7.36 | 10,000.0000 | 0 | 100.00% | 0.00% |
| Nov. 11, 2024 | Grossman Fred | Chief Medical Officer | P | Common Stock, par value $0.0001 per share | 2710 | $7.37 | 2,710.0000 | 0 | 9999.99% | 0.00% |
| Nov. 11, 2024 | Swaminathan Arun | Chief Executive Officer | P | Common Stock, par value $0.0001 per share | 5000 | $7.34 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | Berman Howard | Chief Executive Officer | A | Stock Option (right to buy) | 163663 | $0.00 | 163,663.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | Grossman Fred | Chief Medical Officer | A | Stock Option (right to buy) | 70596 | $0.00 | 70,596.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | SNYDER DAVID S | Chief Financial Officer | A | Stock Option (right to buy) | 70596 | $0.00 | 70,596.0000 | 0 | 9999.99% | 0.00% |
| Aug. 22, 2023 | Lee Ann | Director | P | Common Stock, par value $0.0001 per share | 1000 | $3.62 | 17,479.0000 | 0 | 6.07% | 0.00% |
| Jan. 31, 2024 | Grossman Fred | Chief Medical Officer | A | Stock Option (right to buy) | 74069 | $0.00 | 74,069.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Berman Howard | Chief Executive Officer | A | Stock Option (right to buy) | 189680 | $0.00 | 189,680.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | SNYDER DAVID S | Chief Financial Officer | A | Stock Option (right to buy) | 81819 | $0.00 | 81,819.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2024 | Grossman Fred | Chief Medical Officer | A | Stock Option (right to buy) | 81819 | $0.00 | 81,819.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2024 | Villalobos Anabella | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2024 | Lee Ann | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2024 | GOLDSTEIN DOV A MD | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2024 | Garren Hideki | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2024 | Weinand Dieter | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | ROSS WILBUR L JR | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |